Paper32804232
Peripheral Nerve Stimulation for the 21st Century: Sural, Superficial Peroneal, and Tibial Nerves.
Hanyu-Deutmeyer A and 1 other. Pain Med, 2020. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Peripheral Nerve Stimulation for the 21st Century: Sural, Superficial Peroneal, and Tibial Nerves. Papers, record 32804232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32804232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Peripheral Nerve Stimulation for the 21st Century: Sural, Superficial Peroneal, and Tibial Nerves.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tibial Nerve | Major topic |
| Transcutaneous Electric Nerve Stimulation | Major topic |
| Humans | |
| Lower Extremity | |
| Peripheral Nerves | |
| Peroneal Nerve | |
| Sural Nerve |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42828197 | Percutaneous brachial plexus peripheral nerve stimulation for cancer-related upper extremity pain: a novel technical approach. | Interv Pain Med | 2026 | https://conductscience.org/library/papers/42828197 | PubMed |
| 42445152 | The evolving landscape of minimally invasive procedures in musculoskeletal diseases-Part II. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42445152 | PubMed |
| 41245476 | Consensus Guidelines for the Use of Peripheral Nerve Stimulation in the Treatment of Chronic Pain and Neurological Diseases: A Neuron Project from the American Society of Pain and Neuroscience. | J Pain Res | 2025 | https://conductscience.org/library/papers/41245476 | PubMed |
| 40590046 | Consensus Guidelines from the American Society of Pain and Neuroscience for the Use of 60-Day Peripheral Nerve Stimulation Therapy. A NEURON Living Guideline Project. | J Pain Res | 2025 | https://conductscience.org/library/papers/40590046 | PubMed |
| 38633823 | A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET. | J Pain Res | 2024 | https://conductscience.org/library/papers/38633823 | PubMed |
| 38440795 | Peripheral nerve stimulation for psoas muscle pain. | Pain Manag | 2024 | https://conductscience.org/library/papers/38440795 | PubMed |
| 37369810 | Advantages of ultrasound identification of the distal insertion of the calcaneofibular ligament during ligament reconstructions. | Surg Radiol Anat | 2023 | https://conductscience.org/library/papers/37369810 | PubMed |
| 37027024 | Three-Dimensional Digitalized Virtual Planning of Free Anterior Tibial Artery Perforator Flap for Repairing Soft Tissue Defects in Extremities. | World J Surg | 2023 | https://conductscience.org/library/papers/37027024 | PubMed |
| 35884969 | Peripheral Nerve Stimulation for Lower Extremity Pain. | Biomedicines | 2022 | https://conductscience.org/library/papers/35884969 | PubMed |
| 34745471 | An Update on Peroneal Nerve Entrapment and Neuropathy. | Orthop Rev (Pavia) | 2021 | https://conductscience.org/library/papers/34745471 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32804232
GET https://conductscience.org/api/papers/v1/32804232/authors